These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 26363301)

  • 21. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.
    Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.
    Ramsey JM; Hibbitts A; Barlow J; Kelly C; Sivadas N; Cryan SA
    Ther Deliv; 2013 Jan; 4(1):59-76. PubMed ID: 23323781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins.
    Guagliardo R; Pérez-Gil J; De Smedt S; Raemdonck K
    J Control Release; 2018 Dec; 291():116-126. PubMed ID: 30321577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
    Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
    Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid pulmonary surfactant-coated nanogels mediate efficient in vivo delivery of siRNA to murine alveolar macrophages.
    De Backer L; Naessens T; De Koker S; Zagato E; Demeester J; Grooten J; De Smedt SC; Raemdonck K
    J Control Release; 2015 Nov; 217():53-63. PubMed ID: 26307350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
    Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W
    Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment.
    Yalcin E; Kara G; Celik E; Pinarli FA; Saylam G; Sucularli C; Ozturk S; Yilmaz E; Bayir O; Korkmaz MH; Denkbas EB
    Prep Biochem Biotechnol; 2019; 49(7):659-670. PubMed ID: 31066619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating β
    Merckx P; Conickx G; Blomme E; Maes T; Bracke KR; Brusselle G; De Smedt SC; Raemdonck K
    Eur J Pharm Biopharm; 2024 Apr; 197():114223. PubMed ID: 38367760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.
    Park J; Park J; Pei Y; Xu J; Yeo Y
    Adv Drug Deliv Rev; 2016 Sep; 104():93-109. PubMed ID: 26686832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
    Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
    Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
    Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
    Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
    Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges.
    Bardoliwala D; Patel V; Javia A; Ghosh S; Patel A; Misra A
    Ther Deliv; 2019 May; 10(5):311-332. PubMed ID: 31116099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
    Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
    Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance.
    Qiu Y; Clarke M; Wan LTL; Lo JCK; Mason AJ; Lam JKW
    Mol Pharm; 2021 Jun; 18(6):2218-2232. PubMed ID: 34014665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal delivery of antiviral siRNA.
    Barik S
    Methods Mol Biol; 2011; 721():333-8. PubMed ID: 21431695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.